Longitudinal Assessment of Cardiac MRI Microstructure in Patients and Healthy People
Official title: Longitudinal Validation of CIRC Technologies
Run by The Cleveland Clinic · NCT07081711 · Data updated 2026-11-12
This study tests advanced, non-contrast and extended clinical cardiac MRI techniques to see how heart tissue features differ between people with heart disease and healthy individuals.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | The Cleveland Clinic Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Cleveland, Ohio) |
| Status | Recruiting |
| Started | May 6, 2026 |
| Main results expected | August 2035 |
| Study ends | August 2037 |
| Registry record updated | July 31, 2026 |
| Trial ID | NCT07081711 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 years and older with cardiovascular disease or healthy controls who can undergo MRI and provide informed consent.
✕Probably not a fit
Individuals with contraindications to CMR imaging or those who do not meet inclusion criteria may not experience a direct benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study compares cardiac MRI–derived microstructural tissue phenotypes in adults with cardiovascular disease to those in healthy controls. It uses novel MRI methods that exploit endogenous tissue properties to characterize inflammation, fibrosis, metabolism, and microstructure of the heart. Participants may undergo an extended clinical cardiac MRI or a research non-contrast MRI protocol, with follow-up of medical status for up to five years. The goal is to determine how microstructure relates to heart structure and function and to inform the development of faster, more robust cardiac MRI exams for clinical use. Interventions are not randomized and all procedures are imaging-based.
Why it matters
Potential benefit: If successful, the study could lead to improved MRI-based detection and understanding of heart disease that informs future imaging protocols.
How similar studies have gone: Prior work in cardiac MRI has demonstrated feasibility of tissue characterization; this study extends those methods to compare diseased and healthy cohorts.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years of age * Provision of written informed consent Exclusion Criteria: * Vulnerable populations will be excluded from this study including Prisoners * Other contraindications to CMR imaging to be determined by standard MRI protocols * Decisionally impaired (e.g., dementia or cognitive disability)
Where it's running
-
Cleveland Clinic
Cleveland, Ohio, United States Recruiting
Study contacts
- Study coordinator: Research Coordinator Research Coordinator
- Email: CIRC@ccf.org
- Phone: 216-445-6515
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Development of advanced MRI techniques for heart disease assessment
This study is testing new MRI techniques to see how heart tissue differs between people with heart disease and healthy individuals to improve heart assessments.
-
Registry of brain-heart comorbidity in China
This study is trying to build a big database to better understand and manage the connection between brain and heart problems in people across China.
-
Assessing arterial stiffness and heart disease risk using a novel technology
This study is testing a new, no-touch technology to measure how stiff your arteries are and see if it can help figure out your risk for heart disease.
-
Understanding brain and heart injuries after bleeding in the brain
This study looks at how bleeding in the brain affects both the brain and the heart in adults to better understand the connection between these injuries.
-
AI-based assessment of heart function using ECG wearable monitors
This study tests if a new AI tool using a wearable heart monitor can accurately check heart function in people with heart failure compared to traditional heart scans.
-
Biobank of stem cells and biomarkers for cardiovascular disease
This study is creating a bank of stem cells and blood samples from people with heart disease to help researchers learn more about the condition and find better treatments.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.